Scientists may have found a new way to spot early signs of obesity, which could lead to novel prevention strategies. A study published in the journal Cell Reports has discovered that people living ...

The AACE has updated its guidance on obesity and adiposity-based chronic disease to reflect a focus on improving overall ...

A critical look at metabolically healthy obesity and metabolically unhealthy normal weight—and what they mean for ...

Objectives The 2019 Lancet Commission report introduced the concept of a ‘syndemic’, emphasising the complex interplay between malnutrition, obesity and climate change. This updated systematic review ...

The Obesity Association, a division of the American Diabetes Association (ADA), has issued new standards of care on the ...

Survival horror and action horror are often associated with zombies; if you pick up a game from either niche, chances are that you’ll be tackling hordes of the undead, either with a steel pipe or a ...

Add Yahoo as a preferred source to see more of our stories on Google. Ozempic, pictured in May 2022, contains semaglutide, which is used to treat diabetes and obesity. Health Canada says it is ...

After ushering in a new era of obesity treatment with its GLP-1 medicine Wegovy earlier in the decade, Novo Nordisk is making history again with the first FDA approval of a GLP-1 pill for weight loss.

Code editor provider Cursor has acquired Graphite, a startup with a tool that helps developers check software updates for bugs before releasing them to production. The companies announced the ...

A major review in Frontiers in Science highlights how tackling unsustainable food systems—reflected by our changing food environment—is urgent for both health and climate. The paper reviews evidence ...

SAN FRANCISCO--(BUSINESS WIRE)--CodeRabbit, the leading AI-powered code review platform, today released the “State of AI vs Human Code Generation”, a comprehensive new report analyzing the quality of ...

Top officials at the U.S. FDA have internally urged its reviewers to speed up the evaluation of Eli Lilly’s (LLY) marketing application for its weight loss pill orforglipron after the Indiana-based ...